Because NGS enables us a full view of genetic landscape in NSCLC, taking other molecular alterations into account, if possible, when analyzing the correlation of TMB and clinical benefits of EGFR-TKIs may be more rational. Here, EGFR is linked to non-small cell lung carcinoma.